8:15-8:30 | Welcome and Introductions |
8:30-9:00 | Overview of the Bioelectronic Medicine IndustryJames Cavuoto, Editor, Neurotech ReportsBioElectRx Business Report Editor James Cavuoto presents an overview of the bioelectronic medicine industry, including recent events, key players, technological roots, and market projections. |
9:00-9:30 | Keynote AddressMichel Maharbiz, Ph.D., CEO, iota BiosciencesA bioelectronic medicine industry executive and longtime industry observer offers their views on what lies ahead. |
9:30-10:15 | Bioelectronic Medicine ROIJeremy Koff, Senior Consulting Editor, Neurotech Reports, ModeratorAllan Gobbs, Co-Founder and Managing Partner, ATEM CapitalAdam Rosenwach, Founding Managing Partner, Star51 CapitalJeff Chu, Managing Partner, Features CapitalSeveral recent high-profile exits and investment deals have raised the stakes for entrepreneurs and investors alike. In this session, venture capital professionals active in the life sciences industry will offer their views on the investment climate for bioelectronic medicine. |
10:15-10:45 | Refreshment Break |
10:45-11:30 | Entrepreneur Panel IJames Cavuoto, Editor, Neurotech Reports, ModeratorBen Woodington, Ph.D., CEO, Coherence NeuroMiguel Vilaplana, M.D., CEO, Graphenicalab SLStefan Kampusch, Ph.D., CEO, Aurimod GmbHPresentations from executives of emerging bioelectronic medicine firms. |
11:30-12:15 | Novel Diagnostics Drive New TherapiesJames Cavuoto, Editor, Neurotech Reports, ModeratorNandan Lad, M.D., Ph.D., Professor of Neurosurgery, Duke UniversityMarom Bikson, Ph.D., Professor of Biomedical Engineering, CCNYKiran Patel, M.D., Founder and CEO, NYC Neuromodulation Center of ExcellenceAdvances in bioelectronic medicine have come not only from identifying new neuromodulation targets, but also from integrating novel biological signals into the therapeutic regimen. In this session, experienced investigators and entrepreneurs will offer their thoughts on how new thinking in bioelectronic medicine can yield new opportunities for life science firms. |
12:15-1:15 | Luncheon |
1:15-1:30 | Luncheon Speaker |
1:30-2:15 | Improving Selectivity of Bioelectronic TherapiesVictor Pikov, Ph.D., Contributing Editor, BioElectRx Business Report, ModeratorJay Jiang, Ph.D., CTO, Spiro MedicalEsther Novosel, Ph.D., CEO, neuroloop GmbHThe market for bioelectronic medicine will be driven by improvements in selective activation of both sympathetic and parasympathetic fibers. In this session, we’ll look at some new products that have emerged as a result of advances in selective activation. |
2:15-3:00 | Entrepreneur Panel IIJeremy Koff, Senior Consulting Editor, Neurotech Reports, ModeratorBryan McLaughlin, Ph.D., CEO, ExNeuroAmir Soltanianzadeh, CEO, StimCardio MedicalMehmet Gunal, Ph.D., CEO, Brill NeurotechPresentations from executives of emerging bioelectronic medicine firms. |
3:00-3:30 | Refreshment Break |
3:30-4:15 | Emerging Market SegmentsJoJo Platt, Senior Contributing Editor, Neurotech Reports, ModeratorJeffrey Cohen, Director of Research, Ladenburg ThalmannJohn Propst, Ph.D., Managing Partner, Ground Effect VenturesAdam Caplan, Founder and General Partner, Jumpsapce VenturesIn this session, we’ll look at some of the new opportunities awaiting investors in the space. |
4:15-5:00 | A Fireside ChatJames Cavuoto, Editor, Neurotech Reports, ModeratorJennifer French, Executive Director, Neurotech NetworkNeurotech Reports editors chat with a key figure from the bioelectronic medicine industry. |
5:00-6:30 | Cocktail Reception |
